JOHNSON & JOHNSON DEVELOPMENT CORP
- Tylenol manufacturer McNeil edges closer to re-opening Fort Washington plant The Philadelphia Business Journal - News
- J&J gets $116M to help hustle along new Ebola vaccine Fierce Biotech News
- Baker Botts Reps Depomed In $1B J&J Unit Drug Rights Deal Law 360 Corporate Finance
- J&J Gets Grant to Speed Up Ebola Vaccine Wall Street Journal - US Business
- Depomed, Inc. Smacks Down $1.05 Billion for Johnson & Johnson's Pain Drug Franchise Bio Space - All News
- Isis Pharmaceuticals, Johnson & Johnson Sign $835 Million Deal The San Diego Business Journal - Headlines - San Diego, CA
- J&J inks an $835M RNA deal to develop autoimmune drugs with Isis Fierce Biotech News
- <b>EB Pharma</b> Announces License Agreement For Investigational Drug, Tipifarnib From Janssen Pharm Bio Space - Breaking News
- Neutrogena settles suit over hazardous-waste violations at Los Angeles plant Los Angeles Daily News Breaking News
- Janssen's HIV-1 combination drug awarded approval in Europe American Association of Blood Banks AABB SmartBrief
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on JOHNSON & JOHNSON DEVELOPMENT CORP
- Rate JOHNSON & JOHNSON DEVELOPMENT CORP on their payment behavior
- Ask your network about JOHNSON & JOHNSON DEVELOPMENT CORP with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.